Panagora Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-916,896
| Closed | -$3.76M | – | 1646 |
|
|
2022
Q1 | $3.76M | Buy |
916,896
+74,286
| +9% | +$305K | 0.02% | 483 |
|
|
2021
Q4 | $3.01M | Sell |
842,610
-8,462
| -1% | -$30.2K | 0.02% | 527 |
|
|
2021
Q3 | $3.1M | Sell |
851,072
-14,880
| -2% | -$54.2K | 0.02% | 551 |
|
|
2021
Q2 | $3.78M | Buy |
865,952
+67,077
| +8% | +$292K | 0.02% | 510 |
|
|
2021
Q1 | $3.28M | Buy |
798,875
+13,794
| +2% | +$56.7K | 0.02% | 580 |
|
|
2020
Q4 | $3.13M | Buy |
785,081
+5,306
| +0.7% | +$21.2K | 0.02% | 555 |
|
|
2020
Q3 | $2.11M | Buy |
779,775
+553,942
| +245% | +$1.5M | 0.01% | 620 |
|
|
2020
Q2 | $621K | Buy |
225,833
+79,245
| +54% | +$218K | ﹤0.01% | 1122 |
|
|
2020
Q1 | $346K | Buy |
146,588
+123,748
| +542% | +$292K | ﹤0.01% | 1275 |
|
|
2019
Q4 | $107K | Buy |
+22,840
| New | +$107K | ﹤0.01% | 1787 |
|
|
2019
Q1 | – | Sell |
-460
| Closed | -$1K | – | 2600 |
|
|
2018
Q4 | $1K | Hold |
460
| – | – | ﹤0.01% | 2434 |
|
|
2018
Q3 | $2K | Sell |
460
-1,297,407
| -100% | -$5.64M | ﹤0.01% | 2373 |
|
|
2018
Q2 | $3.35M | Buy |
1,297,867
+2,576
| +0.2% | +$6.65K | 0.01% | 681 |
|
|
2018
Q1 | $2.85M | Buy |
1,295,291
+389,274
| +43% | +$857K | 0.01% | 743 |
|
|
2017
Q4 | $1.8M | Buy |
906,017
+502,552
| +125% | +$1M | 0.01% | 923 |
|
|
2017
Q3 | $1.31M | Buy |
+403,465
| New | +$1.31M | 0.01% | 1025 |
|
|
2016
Q2 | – | Sell |
-1,645,501
| Closed | -$1.43M | – | 2367 |
|
|
2016
Q1 | $1.43M | Buy |
1,645,501
+425,756
| +35% | +$371K | 0.01% | 974 |
|
|
2015
Q4 | $1.48M | Buy |
1,219,745
+341,917
| +39% | +$414K | 0.01% | 918 |
|
|
2015
Q3 | $1.49M | Buy |
877,828
+209,267
| +31% | +$356K | 0.01% | 863 |
|
|
2015
Q2 | $1.39M | Buy |
668,561
+186,890
| +39% | +$389K | 0.01% | 953 |
|
|
2015
Q1 | $1.31M | Buy |
+481,671
| New | +$1.31M | 0.01% | 964 |
|